Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Sell
44
GRDN Quote, Financials, Valuation and Earnings
Last price:
$29.34
Seasonality move
:
-19.56%
Day range:
$29.17 - $29.82
52-week range:
$17.78 - $37.43
Dividend yield:
0%
P/E ratio:
46.06x
P/S ratio:
1.33x
P/B ratio:
10.10x
Volume:
189.4K
Avg. volume:
344K
1-year change:
18.37%
Market cap:
$1.9B
Revenue:
$1.2B
EPS (TTM):
$0.64
Analysts' Opinion
-
Consensus RatingGuardian Pharmacy Services, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 3 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $34.00, Guardian Pharmacy Services, Inc. has an estimated upside of 15.96% from its current price of $29.32.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $32.00 representing 100% downside risk from its current price of $29.32.
Fair Value
-
According to the consensus of 3 analysts, Guardian Pharmacy Services, Inc. has 15.96% upside to fair value with a price target of $34.00 per share.
GRDN vs. S&P 500
-
Over the past 5 trading days, Guardian Pharmacy Services, Inc. has underperformed the S&P 500 by -0.19% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Guardian Pharmacy Services, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Guardian Pharmacy Services, Inc. has grown year-over-year revenues for 15 quarters straight. In the most recent quarter Guardian Pharmacy Services, Inc. reported revenues of $377.4M.
Earnings Growth
-
Guardian Pharmacy Services, Inc. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Guardian Pharmacy Services, Inc. reported earnings per share of $0.15.
Enterprise value:
1.9B
EV / Invested capital:
8.12x
Price / LTM sales:
1.33x
EV / EBIT:
31.52x
EV / Revenue:
1.34x
PEG ratio (5yr expected):
--
EV / Free cash flow:
27.36x
Price / Operating cash flow:
27.19x
Enterprise value / EBITDA:
23.05x
Gross Profit (TTM):
$274.3M
Return On Assets:
11.21%
Net Income Margin (TTM):
2.85%
Return On Equity:
24.04%
Return On Invested Capital:
19.18%
Operating Margin:
4.46%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $989.2M | $1.2B | $1.4B | $314.4M | $377.4M | |
| Gross Profit | $148.8M | $229.5M | $274.3M | $60.9M | $74.7M | |
| Operating Income | $23.8M | -$86M | $59.2M | -$104.6M | $16.8M | |
| EBITDA | $41.1M | -$66.7M | $80.9M | -$99.6M | $22.7M | |
| Diluted EPS | $0.25 | -$1.76 | $0.64 | -$1.93 | $0.15 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $104M | -- | -- | $180.3M | $198.3M | |
| Total Assets | $229.9M | -- | -- | $348M | $390M | |
| Current Liabilities | $108.1M | -- | -- | $158.3M | $161.9M | |
| Total Liabilities | $171.9M | -- | -- | $214.1M | $194.5M | |
| Total Equity | $57.9M | -- | -- | $133.9M | $195.5M | |
| Total Debt | $33.5M | -- | -- | $57.9M | $27.4M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $73.6M | $50.2M | $88M | -$2.2M | $28.2M | |
| Cash From Investing | -$16.8M | -$24.9M | -$32.5M | -$7.1M | -$8.6M | |
| Cash From Financing | -$57.2M | $11.4M | -$56.2M | $44.9M | -$1.9M | |
| Free Cash Flow | $56.8M | $35.5M | $68.2M | -$7.3M | $23M | |
GRDN
Sector
Market Cap
$1.9B
$28.8M
Price % of 52-Week High
78.33%
51.13%
Dividend Yield
0%
0%
Shareholder Yield
0.82%
-1.32%
1-Year Price Total Return
18.37%
-20.64%
Beta (5-Year)
--
0.520
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$29.16
200-day SMA
Buy
Level
$23.73
Bollinger Bands (100)
Buy
Level
22.59 - 29.01
Chaikin Money Flow
Buy
Level
2M
20-day SMA
Buy
Level
$29.13
Relative Strength Index (RSI14)
Buy
Level
56.26
ADX Line
Buy
Level
30.66
Williams %R
Neutral
Level
-38.9937
50-day SMA
Buy
Level
$27.32
MACD (12, 26)
Buy
Level
0.39
25-day Aroon Oscillator
Sell
Level
-24
On Balance Volume
Neutral
Level
4.6M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (7.2952)
Sell
CA Score
(Annual)
Level (-0.8088)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (1.6822)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (9)
Buy
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Guardian Pharmacy Services, Inc. engages in the provision of client service and resident care to long-term care communities. It offers assisted living and skilled nursing, group homes, behavioral health and organizations that serve individuals with intellectual and developmental disabilities. The company was founded by Fred Burke, David Morris, and Kendall Forbes on July 21, 2003 and is headquartered in Atlanta, GA.
Stock Forecast FAQ
In the current month, GRDN has received 3 Buy ratings 0 Hold ratings, and 0 Sell ratings. The GRDN average analyst price target in the past 3 months is $34.00.
-
Where Will Guardian Pharmacy Services, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Guardian Pharmacy Services, Inc. share price will rise to $34.00 per share over the next 12 months.
-
What Do Analysts Say About Guardian Pharmacy Services, Inc.?
Analysts are divided on their view about Guardian Pharmacy Services, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Guardian Pharmacy Services, Inc. is a Sell and believe this share price will drop from its current level to $32.00.
-
What Is Guardian Pharmacy Services, Inc.'s Price Target?
The price target for Guardian Pharmacy Services, Inc. over the next 1-year time period is forecast to be $34.00 according to 3 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is GRDN A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Guardian Pharmacy Services, Inc. is a Buy. 3 of 3 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of GRDN?
You can purchase shares of Guardian Pharmacy Services, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Guardian Pharmacy Services, Inc. shares.
-
What Is The Guardian Pharmacy Services, Inc. Share Price Today?
Guardian Pharmacy Services, Inc. was last trading at $29.34 per share. This represents the most recent stock quote for Guardian Pharmacy Services, Inc.. Yesterday, Guardian Pharmacy Services, Inc. closed at $29.32 per share.
-
How To Buy Guardian Pharmacy Services, Inc. Stock Online?
In order to purchase Guardian Pharmacy Services, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get GRDN Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
GRDN
Sector
P/E ratio
46.06x
23.71x
PEG ratio
--
-0.01x
P/B ratio
10.10x
1.84x
Price / LTM sales
1.33x
1.60x
Growth Metrics
GRDN
Sector
Revenue growth
20.05%
4.85%
Earnings growth
108.03%
11.15%
Revenue (5-year growth)
11.96%
6.45%
Earnings forecast
$0.24
-$0.20
Profitability
GRDN
Sector
Profitability FY 2024
$235M
$3.6M
Return on invested capital
19.18%
-30.98%
Return on assets
11.21%
-27.62%
Return on equity
24.04%
-36.69%
Earnings Date
Last Earnings Date
Nov
10
Next Earnings Date
Mar
25
Estimated Next Earnings Date
Feb
9
Balance Sheet
GRDN
Sector
Total cash
$36.5M
$27.2M
Short term investments
--
$25.7M
Total assets
$335.3M
$79.7M
Long term debt
$27.4M
$4.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
How High Could NVIDIA Stock Go?
NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 62x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 38x
Buy
63
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 40x
Alerts
Buy
54
SMX alert for Dec 5
SMX (Security Matters) Plc [SMX] is up 154.74% over the past day.
Sell
15
HOV alert for Dec 5
Hovnanian Enterprises, Inc. [HOV] is down 22.58% over the past day.
Buy
67
NUTX alert for Dec 5
Nutex Health, Inc. [NUTX] is up 18.9% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
